Close

content

Pharmaceutical Supply Chains Ready to Manage the ‘Biggest Security Challenge for a generation’ as the World awaits new Covid Vaccine

Pharmaceutical supply chains are about to face their biggest security challenge for a generation as the world prepares for life-changing deliveries of Covid vaccines,...

Vibalogics establishes U.S. presence with virotherapy facility in Boston and plans to invest $150m

Vibalogics, a global contract development and manufacturing organization (CDMO), has today announced that it has initiated Phase I of its planned $150m investment in...

Stelis starts next phase of investment into its biologics manufacturing facility

Contract development and manufacturing organization (CDMO), Stelis BioSource, a division of Stelis Biopharma, has started the next phase of its continued investment program after...

InSilicoTrials presents a suite of highly innovative products that could revolutionize the global pharmaceutical industry

The global drug discovery market is growing rapidly: it is expected that it will reach 71 billion dollars by 2025, while in 2016 it...

Altimmune Adds Lonza as a Manufacturing Partner for Supply of AdCOVID its Single-Dose Intranasal Vaccine Candidate for COVID-19

Altimmune, Inc., a clinical-stage biopharmaceutical company, announced that it entered into an agreement with Lonza for the manufacturing of AdCOVID™, Altimmune’s next-generation, single-dose intranasal...

Facing The Chinese Challenge – Are Indian Pharmaceutical Companies Up For It?

For long India has been known to supply the world with pharmaceuticals at a very reasonable price. With that being said, immediately our focus...

The Falling Graph of Dose Contract Manufacturing

One could witness slow revenue growth of Dose Contract Manufacturing Organizations in 2019. Expectations were high on its revival in 2020, but unfortunately, things...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from up to 5 devices at once

Must read